Ryan N. Henderson

Array ( [id] => 6717562 [patent_doc_number] => 20030028910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in DNA encoding orphan nuclear receptor ERRalpha' [patent_app_type] => new [patent_app_number] => 09/925720 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14045 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20030028910.pdf [firstpage_image] =>[orig_patent_app_number] => 09925720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5927044 [patent_doc_number] => 20020116732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Microinjection assembly and methods for microinjecting and reimplanting avian eggs' [patent_app_type] => new [patent_app_number] => 09/919143 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9837 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20020116732.pdf [firstpage_image] =>[orig_patent_app_number] => 09919143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015086 [patent_doc_number] => 20010051611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectors' [patent_app_type] => new [patent_app_number] => 09/912680 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9293 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051611.pdf [firstpage_image] =>[orig_patent_app_number] => 09912680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828488 [patent_doc_number] => 20020068324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Transgenic mice containing melanocortin-3 receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/903395 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20195 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068324.pdf [firstpage_image] =>[orig_patent_app_number] => 09903395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6746815 [patent_doc_number] => 20030023998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Transgenic mice containing 5-HT-2B gene disruptions' [patent_app_type] => new [patent_app_number] => 09/903376 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20120 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023998.pdf [firstpage_image] =>[orig_patent_app_number] => 09903376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 38867 [patent_doc_number] => RE041572 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-08-24 [patent_title] => 'Blow molding device for producing thermoplastic containers' [patent_app_type] => reissue [patent_app_number] => 12/099024 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3103 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041572.pdf [firstpage_image] =>[orig_patent_app_number] => 12099024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6689898 [patent_doc_number] => 20030033624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Transgenic mice containing adrenomedullin receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/900519 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19109 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20030033624.pdf [firstpage_image] =>[orig_patent_app_number] => 09900519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6836288 [patent_doc_number] => 20030163834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5' [patent_app_type] => new [patent_app_number] => 09/888182 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6767 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20030163834.pdf [firstpage_image] =>[orig_patent_app_number] => 09888182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5791851 [patent_doc_number] => 20020162131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Transgenic mice containing cerberus gene disruptions' [patent_app_type] => new [patent_app_number] => 09/887552 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19405 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20020162131.pdf [firstpage_image] =>[orig_patent_app_number] => 09887552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445275 [patent_doc_number] => 20020177134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Transgenic mice containing PAFR gene disruptions' [patent_app_type] => new [patent_app_number] => 09/887541 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19657 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177134.pdf [firstpage_image] =>[orig_patent_app_number] => 09887541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6049055 [patent_doc_number] => 20020169307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Transgenic mice containing LPR5 gene disruptions' [patent_app_type] => new [patent_app_number] => 09/887540 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19210 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169307.pdf [firstpage_image] =>[orig_patent_app_number] => 09887540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999854 [patent_doc_number] => 20020028488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Transgenic avian species for making human and chimeric antibodies' [patent_app_type] => new [patent_app_number] => 09/884579 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24567 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028488.pdf [firstpage_image] =>[orig_patent_app_number] => 09884579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6294908 [patent_doc_number] => 20020056146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Transgenic mice containing nuclear hormone receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/883093 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19970 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20020056146.pdf [firstpage_image] =>[orig_patent_app_number] => 09883093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032049 [patent_doc_number] => 20020018769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA' [patent_app_type] => new [patent_app_number] => 09/875264 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7192 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018769.pdf [firstpage_image] =>[orig_patent_app_number] => 09875264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590065 [patent_doc_number] => 20020041869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Methods for treating cells' [patent_app_type] => new [patent_app_number] => 09/878136 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4881 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20020041869.pdf [firstpage_image] =>[orig_patent_app_number] => 09878136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679160 [patent_doc_number] => 20030167492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'TRANSGENIC NON-HUMAN ANIMALS EXPRESSING A GDF-11 DOMINANT NEGATIVE POLYPEPTIDE, AND METHODS OF MAKING AND USING SAME' [patent_app_type] => new [patent_app_number] => 09/871604 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19171 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20030167492.pdf [firstpage_image] =>[orig_patent_app_number] => 09871604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6471025 [patent_doc_number] => 20020022034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Therapeutic DNA vaccination' [patent_app_type] => new [patent_app_number] => 09/863606 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20716 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022034.pdf [firstpage_image] =>[orig_patent_app_number] => 09863606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 760001 [patent_doc_number] => 07011827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Compositions and methods for producing and using homogenous neuronal cell transplants' [patent_app_type] => utility [patent_app_number] => 09/862204 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 20 [patent_no_of_words] => 9475 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/011/07011827.pdf [firstpage_image] =>[orig_patent_app_number] => 09862204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220825 [patent_doc_number] => 20040072285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Induction of apoptosis and cell growth inhibition by protein 4.33' [patent_app_type] => new [patent_app_number] => 10/276491 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 29309 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072285.pdf [firstpage_image] =>[orig_patent_app_number] => 10276491 [rel_patent_id] =>[rel_patent_doc_number] =>)